The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of Familial Hypercholesterolaemia

Elsevier

Available online 26 January 2023

Journal of Clinical LipidologyAuthor links open overlay panelHighlights•

Lp(a)-associated cholesterol is not accounted for in the Friedwald equation

Adjusting estimated LDL-C by Lp(a) improves accuracy of FH diagnostic criteria

However, this approach may lead to patients with an FH mutation being missed

AbstractBackground

: Familial Hypercholesterolaemia (FH) diagnostic tools help prioritise patients for genetic testing and include LDL-C estimates commonly calculated using the Friedewald equation. However, cholesterol contributions from lipoprotein(a) (Lp(a)) can overestimate ‘true’ LDL-C, leading to potentially inappropriate clinical FH diagnosis.

Objective

: To assess how adjusting LDL-C for Lp(a)-cholesterol affects FH diagnoses using Simon Broome (SB) and Dutch Lipid Clinic Network (DLCN) criteria.

Methods

: Adults referred to a tertiary lipid clinic in London, UK were included if they had undergone FH genetic testing based on SB or DLCN criteria. LDL-C was adjusted for Lp(a)-cholesterol using estimated cholesterol contents of 17.3%, 30% and 45%, and the effects of these adjustments on reclassification to ‘unlikely’ FH and diagnostic accuracy were determined.

Results

: Depending on the estimated cholesterol content applied, LDL-C adjustment reclassified 8-23% and 6-17% of patients to ‘unlikely’ FH using SB and DLCN criteria, respectively. The highest reclassification rates were observed following 45% adjustment in mutation-negative patients with higher Lp(a) levels. This led to an improvement in diagnostic accuracy (46% to 57% with SB, and 32% to 44% with DLCN following 45% adjustment) through increased specificity. However all adjustment factors led to erroneous reclassification of mutation-positive patients to ‘unlikely’ FH.

Conclusion

: LDL-C adjustment for Lp(a)-cholesterol improves the accuracy of clinical FH diagnostic tools. Adopting this approach would reduce unnecessary genetic testing but also incorrectly reclassify mutation-positive patients. Health economic analysis is needed to balance the risks of over- and under-diagnosis before LDL-C adjustments for Lp(a) can be recommended.

Keywords

Familial Hypercholesterolaemia

LDL-cholesterol

Lipoprotein(a)

Simon Broome criteria

Dutch lipid Clinic Network criteria

© 2023 Published by Elsevier Inc. on behalf of National Lipid Association.

留言 (0)

沒有登入
gif